Reyvow (Lasmiditan) For Migraine Headaches Gets FDA Approval
The U.S. Food and Drug Administration has approved Eli Lilly and Company's Reyvow (lasmiditan) tablets for acute treatment of migraine headaches in adults. Though used colloquially by everyone who…